This trial is evaluating whether Comprehensive behavioral intervention will improve 1 primary outcome and 11 secondary outcomes in patients with Syndrome. Measurement will happen over the course of Through study completion, an average of 3 months.
This trial requires 20 total participants across 2 different treatment groups
This trial involves 2 different treatments. Comprehensive Behavioral Intervention is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.
Each individual disease component in patients in the syndrome has different causes: this includes metabolic syndrome, lipid profile and lipid metabolism, thyroid dysfunction of the thyroid gland, vitamin deficiency, inflammation, nephritis or malignancy. For syndrome to be reversed, it is required to cure such disease components.
There is some evidence that syndromes may be caused by a combination of certain characteristics in a person. For example, having the right combination of personality traits can cause people to get sick when others are well.\n\n- Mental disorder\n- Psychological trait"
"Fishing bait\n\nFishing bait is a type of artificial substance which is normally used to draw a fish into a fisher's net or a fish trap. Fishing bait is intended to simulate the natural foraging behaviour of a fish to attract fish. It is thus classified alongside fish lures as a form of artificial lure.
The sign of syndromic osteoporosis in adults, including the presence of fracture, and radix nigrabdominis syndrome, a common complication of osteoporosis, in females, may be the same disease. Furthermore, the use of a standard skeleton X-ray for the determination of bone density appears to be unreliable and should not be relied upon as a screening instrument for osteoporosis without the help of dual energy X-ray absorptiometry measurement.
There were a number of reasons for these results, but the main one was the lack of knowledge of some physicians and patients of Syndrome A in the past. Even though there were a lot of patients, clinicians and parents should be more aware of Syndrome A and its prevalence.
Syndrome can be used as a substitute for a clinical diagnosis, by creating a clinically useful and meaningful way to represent a range of conditions through the use of clinical terms. Syndromes offer an attractive alternative in the field of primary care and clinical epidemiology as they help to simplify and illustrate clinical problems.
This classification of the syndromes into basic (basic developmental disorders) and syndromes with developmental delay (i.e. multiple disabilities of childhood) is useful in directing management and in the planning of services. It facilitates comparison and the identification of common trends in clinical practice.
[The syndroma, which is an abbreviation of Syndrome, is the most recent article to be published about syndrome, published in January 2016. Please use Syndroma (www.withpower.com/syndroma) to access these articles.] To gain a better understanding about this syndrome, visit Syndromes.org, which has the most recent updated articles about syndromes.org. Syndromes.org offers patients a place to connect to other patients who match your symptoms. Syndromes.org's goal is not only to provide the latest information about syndromes, but to have patients meet other patients who are going through similar Syndromes.com, Syndromes.org, Syndromes.
There are two major genetic systems that produce susceptibility or resistance to rheumatic diseases. Aspects of these conditions appear to run in families as is frequently reported with other rheumatic diseases.
With a median follow-up time of 1.3 years, no evidence of sustained deleterious effects was found with respect to the frequency of moderate to severe symptoms of depression or anxiety in our sample.
The new development in treatment research for substance-using individuals with a history of trauma-and-abuse needs to address four main themes: integrating cognitive-behavioral therapy into drug addiction treatment models; emphasizing trauma treatment as a core treatment approach; developing trauma-informed treatments that integrate cognitive-behavioral therapy with trauma psychotherapy; and incorporating trauma-informed trauma treatment approaches into clinical models of addiction treatment.
There have been few clinical studies employing comprehensive behavioral intervention for adolescent and adult smokers. Most of them were case-reports or summaries of earlier studies. Such studies failed to provide sufficient quality evidence for making a firm recommendation about the effects of comprehensive behavioral intervention on smoking behavior. At present, we recommend that this topic be included in the agenda of future multi-center clinical trials.
There may be potential for significant advances in knowledge to be made based on syndrome. The identification of specific syndrome groups for which new therapies may be effective is of particular importance.